Keio University-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Keio University - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014095
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Keio University (Keio) is an educational institution that offers academic and research in various fields. The university provides primary and secondary education, graduate and undergraduate courses, and information technology courses. It offers academic courses in the field of economics, law, humanities and social science, political science, and others. Keio also offers studies on environment and information studies, policy management, business and commerce, medicine, nursing and pharmaceutical sciences. The university provides elementary education through its schools, and university hospital. It operates through its campuses located in Mita, Hiyoshi, Yagami, Shinanomachi, Tonomachi, Tsuruoka, and others. Keio is headquartered in Tokyo, Japan.

Keio University – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Keio University, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Keio University, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Keio University, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Keio University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Keio University, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Keio University, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Eisai Enters into Agreement with Keio University 10
Takeda Enters into Research Agreement with Keio University School of Medicine and Niigata University 11
R-Tech Ueno Enters Into Co-Development Agreement With Keio University School Of Medicine 12
tella Enters into Research Agreement with Keio University School of Medicine 13
tella Enters into Research Agreement with Keio University School of Medicine for Esophageal Cancer 14
Licensing Agreements 15
Elixirgen Enters into License Agreement with Keio University 15
Keio University – Key Competitors 16
Keio University – Key Employees 17
Keio University – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Keio University, Pharmaceuticals & Healthcare, Key Facts 2
Keio University, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Keio University, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Keio University, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Keio University, Deals By Therapy Area, 2011 to YTD 2017 8
Keio University, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Eisai Enters into Agreement with Keio University 10
Takeda Enters into Research Agreement with Keio University School of Medicine and Niigata University 11
R-Tech Ueno Enters Into Co-Development Agreement With Keio University School Of Medicine 12
tella Enters into Research Agreement with Keio University School of Medicine 13
tella Enters into Research Agreement with Keio University School of Medicine for Esophageal Cancer 14
Elixirgen Enters into License Agreement with Keio University 15
Keio University, Key Competitors 16
Keio University, Key Employees 17
Keio University, Other Locations 18
Keio University, Subsidiaries 18

★海外企業調査レポート[Keio University-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Karambunai Corporation Berhad:戦略・SWOT・企業財務分析
    Karambunai Corporation Berhad - Strategy, SWOT and Corporate Finance Report Summary Karambunai Corporation Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Yissum Research Development Company of the Hebrew University of Jerusalem Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Yissum Research Development Company of the Hebrew University of Jerusalem Ltd (YRDC) is a technology transfer company that offers marketing the inventions and know-how generated by the University's researchers and students. The company’s products include exelon, doxil, cherry tomatoes and lo …
  • Full House Resorts Inc:戦略・SWOT・企業財務分析
    Full House Resorts Inc - Strategy, SWOT and Corporate Finance Report Summary Full House Resorts Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Qenos Pty Ltd:企業の戦略的SWOT分析
    Qenos Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Indago Energy Ltd (INK):石油・ガス:M&Aディール及び事業提携情報
    Summary Indago Energy Ltd (Indago), formerly Pryme Energy Ltd is a provider of specialist oil and gas production chemicals. The company offers acquisition, up-gradation, exploration and production services to onshore oil and natural gas. It holds interests in the Newkirk project located in Kay Count …
  • BelAZ:企業の戦略・SWOT・財務分析
    BelAZ - Strategy, SWOT and Corporate Finance Report Summary BelAZ - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, provid …
  • UCL Business PLC-製薬・医療分野:企業M&A・提携分析
    Summary UCL Business PLC (UCLB), a subsidiary of University College London is a technology transfer company that supports and markets research and innovations. The company offers licensing technologies and innovations, creates shared risk joint venture businesses, and promotes and supports the trans …
  • Miragen Therapeutics Inc (MGEN):企業の財務・戦略的SWOT分析
    Miragen Therapeutics Inc (MGEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • NanoCarrier Co Ltd (4571):企業の財務・戦略的SWOT分析
    Summary NanoCarrier Co Ltd (NanoCarrier) is a drug development company that develops and produces pharmaceuticals using micellar nanoparticles technology. The company’s pipeline products include NC-6004, NC-4016, NC-6300, VB-111, NC-6201 and NK105. It offers siRNA micelle, protein micelle, DACH-plat …
  • Paychex, Inc. (PAYX):企業の財務・戦略的SWOT分析
    Paychex, Inc. (PAYX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Fresh Del Monte Produce Inc.:企業の戦略・SWOT・財務情報
    Fresh Del Monte Produce Inc. - Strategy, SWOT and Corporate Finance Report Summary Fresh Del Monte Produce Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Abreos Biosciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Abreos Biosciences Inc (Abreos) is a biotechnology company with focus on the development of laboratory-based and point-of-care (POC) assays and reagents for the precision dose monitoring of biologic drugs. Its Monator, is a drug-monitoring test that provides physicians with vital information …
  • Heroux-Devtek Inc:企業の戦略・SWOT・財務分析
    Heroux-Devtek Inc - Strategy, SWOT and Corporate Finance Report Summary Heroux-Devtek Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Soleno Therapeutics Inc (SLNO):医療機器:M&Aディール及び事業提携情報
    Summary Soleno Therapeutics Inc (Soleno), formerly Capnia Inc is a medical equipment company that designs, develops and commercializes novel therapeutic and diagnostic products. The company provides products such as serenz, cosense, and others. It offers serenz which is a hand-held device, which is …
  • New World Development Co Ltd (17):企業の財務・戦略的SWOT分析
    New World Development Co Ltd (17) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Cogeco Inc:企業の戦略・SWOT・財務情報
    Cogeco Inc - Strategy, SWOT and Corporate Finance Report Summary Cogeco Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Vikas WSP Ltd (519307):企業の財務・戦略的SWOT分析
    Vikas WSP Ltd (519307) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Z Energy Ltd
    Z Energy Ltd - Strategy, SWOT and Corporate Finance Report Summary Z Energy Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • JK Paper Ltd.:企業の戦略・SWOT・財務情報
    JK Paper Ltd. - Strategy, SWOT and Corporate Finance Report Summary JK Paper Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Nephros Inc (NEPH)-医療機器分野:企業M&A・提携分析
    Summary Nephros Inc (Nephros) is medical device company that develops and markets filtration products. The company offers infection control filters, dialysis ultrafilters, and hemodia filtration systems. Its dialysis ultrafilters are intended to be used to filter water and bicarbonate concentrate us …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆